The Scientist - Home

A pill is shown on a blue technical background. One half of the pill has a DNA helix on it, and the other half has a depiction of a computer chip, representing the role of artificial intelligence in drug development.
| 3 min read
2026 will be the year that artificial intelligence accelerates multiple aspects of the drug discovery and development pipeline, industry leaders predict.

Latest

The Scientist Placeholder Image

Gallo Investigation: A `Messy Business' Raises Many Issues

The Scientist Placeholder Image

Notebook

The Scientist Placeholder Image

`21st-Century' Facility Is Bound For Seattle

The Scientist Placeholder Image

Biotech Bottleneck: Can Support From Bush, FDA Speed Things Up?

The Scientist Placeholder Image

Finding What Works: American Scientists Ponder Ways To Aid Ex-Soviet Colleagues

The Scientist Placeholder Image

Suppliers Offering Solid-State, Tunable,Ultrafast Lasers

The Scientist Placeholder Image

Low Pay And Occupational Hazards Trouble Some Industrial Chemists

The Scientist Placeholder Image

Notebook

The Scientist Placeholder Image

FASEB 1992 In Anaheim: Getting The Message Into Cells

The Scientist Placeholder Image

The ACS Meeting: Stirring Things Up

The Scientist Placeholder Image

American Indians In Science: Moving Forward, But Slowly

The Scientist Placeholder Image

New NSF Structure Reflects Broad Agency Reorientation

February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies